• logo
  • UKUK
  • Products
    • Search for Product
      • Product Name

        Keyword Search

    • Featured Products




  • News
  • Library
  • Facilities
  • Contacts
boviseal boviseal endospec 2.5 boviseal endospec 10 Stalosan F Endofluke - protect your cows from fluke boviseal

Global Excellence in Animal Health

Bimeda® is a leading global manufacturer, marketer and distributor of animal health products and veterinary pharmaceuticals. Through ongoing expansion and strategic acquisition, Bimeda® has established markets in more than seventy countries worldwide and has R&D, manufacturing and distribution capabilities across Europe, North America, South America, Africa, Asia and Australasia. Bimeda® employs almost 800 employees worldwide and has its global headquarters in Carrickmines, Dublin, Ireland.  Bimeda® is focused on providing a comprehensive, customer-driven service, selling consistently high-quality products, at a market-conscious price level.

Bimeda UK’s headquarters have been based in Anglesey, Wales, since 1998. The Bimeda UK product portfolio focuses on five key categories; nutrition, parasite control, dairy production, equine and pig & poultry.

Watch our corporate video or visit Bimeda.com to learn more.

Bimeda Global

global map

Corporate Video

corporate video

Bimeda News

Published: July 25, 2016
Bimeda UK is proud to communicate the launch of their guide to selective dry cow therapy. The 8 page, A5 guide is available to vets throughout the UK, who wish to consider a move to selective dry cow therapy (SDCT) for some of their clients. The guide will assist vets…
Published: July 07, 2016
Bimeda UK is pleased to announce the re-launch of Multishield Dry Cow (POM-V) to the UK market place. The non-cephalosporin containing dry cow tube contains 100mg Neomycin Sulphate, 100mg Penethemate Hydriodide and 400mg Procaine Benzylpenicillin and is a welcome addition to Bimeda’s growing dairy production category, which includes such products…
Published: July 05, 2016
Bimeda is pleased to be attending the 2016 World Buiatrics Congress, which is taking place in Dublin this year and which is attended by over 3000 delegates. Bimeda’s wide range of animal health and veterinary pharmaceutical products and their global footprint, means that the Bimeda trade stand is proving extremely…
Published: July 04, 2016
Bimeda UK is pleased to announce the launch of Tetroxy Vet injection (200mg/ml oxytetracycline, POM-V). The range is the latest addition to the company’s broad and expanding dairy-production category. Head of Sales for Bimeda UK, James Hutchings, commented; ‘the launch of Tetroxy Vet highlights our ongoing commitment to providing UK…


No events